Houston, TX, United States of America

Urs Albrecht

This inventor holds 2 USPTO granted patents. Top assignee: Research Development Foundation. Active years: 2001.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Urs Albrecht. Retrieved from https://idiyas.com/inventor/urs-albrecht

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 4.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2001

Loading Chart...
2 patents (USPTO):Explore Patents

Title: The Innovations of Urs Albrecht

Introduction

Urs Albrecht is a notable inventor based in Houston, TX (US). He has made significant contributions to the field of genetics, particularly in the study of circadian rhythms. With a total of 2 patents, his work has implications for understanding biological clocks in mammals.

Latest Patents

Albrecht's latest patents include the "Mammalian circadian regulator M-RIGUI2 (MPER2)" and the "Mammalian circadian rhythm-like gene." The first patent provides DNA encoding a m-rigui2 protein, which includes isolated DNA that encodes the protein and vectors capable of expressing this DNA in recombinant cells. The second patent similarly provides DNA encoding a RIGUI protein, along with vectors and regulatory elements necessary for expression in host cells.

Career Highlights

Urs Albrecht is associated with the Research Development Foundation, where he continues to advance his research in genetics. His work has garnered attention for its potential applications in various biological and medical fields.

Collaborations

Albrecht has collaborated with notable scientists such as Gregor Eichele and Cheng-Chi Lee, contributing to a rich exchange of ideas and research findings.

Conclusion

Urs Albrecht's innovative work in the field of genetics, particularly regarding circadian rhythms, showcases his dedication to advancing scientific knowledge. His patents reflect a commitment to understanding complex biological processes, which may lead to significant advancements in health and medicine.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…